neoadjuvant abemaciclib

Interviews and expert commentary tagged “neoadjuvant abemaciclib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Paul H Cottu MD PhD, ESMO Berlin: Chemo-Free Regimen with Neoadjuvant CDK 4/6 Inhibition plus Endocrine Therapy Benefits Patients with High-Risk ER+ HER2- Early Breast Cancer
Audio Journal of Oncology

Paul H Cottu MD PhD, ESMO Berlin: Chemo-Free Regimen with Neoadjuvant CDK 4/6 Inhibition plus Endocrine Therapy Benefits Patients with High-Risk ER+ HER2- Early Breast Cancer

Aan identifyable subset of patients with high-risk ER+ HER2- early breast cancer better off without chemotherapy

24 November 2025
0:00
← Browse all episodes